The effects of the glutamate N-methyl-D aspartate receptor antagonist MK-80l in reducing isch aemic brain damage have been examined in anaesthetised cats, with drug treatment being initiated 2 h after the in duction of cerebral ischaemia. Focal cerebral ischaemia was produced by permanent occlusion of one middle ce rebral artery, and the animals were killed 6 h later. The amount of early irreversible ischaemic damage was as sessed at 16 predetermined stereotactic planes. Tr eat ment with MK-801 (5 mg/kg, i.v.) 2 h after middle cere-
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The marked elevation in extracellular concentra tion of glutamate in cerebral ischaemia is putatively a major factor in the sequence of cellular events that results in ischaemic damage to neurones (Mel drum, 1985; Rothman and Olney, 1987) .
There is increasing evidence that pretreatment with glutamate receptor antagonists, particularly antagonists of the N-methyl-D-aspartate (NMDA) receptor subtype, can protect against the effects of bral artery occlusion reduced significantly the volume of ischaemic damage (from 1,625 ± 384 mm3 of the cerebral hemisphere in vehicle-treated cats to 792 ± 385 mm3 in MK-801-treated cats). The demonstration of reduced ischaemic brain damage with MK-801, when the agent is administered after the induction of ischaemia, extends the therapeutic potential of such agents in the treatment of focal cerebral ischaemia in humans. Key Words: Gluta mate-Cerebrovascular disease-Cerebral ischaemia NMDA antagonists.
cerebral ischaemia in a variety of animal models (Simon et aI., 1984; Gill et aI., 1987; Ozyurt et aI., 1988; Boast et aI., 1988) . It has not yet been estab lished that treatment, after the induction of isch aemia, with glutamate receptor antagonists ame liorates cerebral ischaemia in a reliable model in a mature animal. In the present study, we examined the effect of post-ischaemic, systemic treatment with MK-801, an NMDA antagonist that crosses the blood-brain barrier (Wong et aI., 1986) , in a cat model of focal cerebral ischaemia. We have re ported previously that pretreatment with MK-801 markedly protects against ischaemia-induced brain damage in this model (Ozyurt et aI., 1988) .
MATERIALS AND METHODS
The investigations were carried out in 15 cats weighing between 2 and 4.4 kg. The cat was anaesthetised initially with thiopentone (25 mg/kg Lv.), intubated, and con nected to a positive pressure ventilator delivering nitrous oxide and oxygen in an open circuit. Polyethylene cath eters were inserted into one femoral vein and artery for the administration of drugs and the continuous moni toring of arterial blood pressure, respectively. Anaes thesia was maintained throughout the course of the in-vestigation with chloralose (60 mg/kg i. v., supplemented as necessary to prevent the return of the corneal reflex). Throughout the experimental period, the animals were maintained in a normotensive state (MABP >80 mm Hg). Normocapnia (arterial Pe02 close to 32 mm Hg) was maintained by adjusting the stroke volume of the respi rator. Metabolic acidosis was corrected by administration of sodium bicarbonate (8.4%). Regular samples of arterial blood were taken for the determination of respiratory status using a direct reading electrode system (Corning 168 Blood Gas Analyzer, Corning Medical, Medfield, MA, U.S.A., and plasma glucose automated assay based on the glucose oxidase reaction (Beckman Glucose Ana lyser 2, Beckman Instruments Inc., Fullerton, CA, U.S.A.).
The left middle cerebral artery (MCA) was perma nently occluded by a neurosurgeon using a transorbital approach. The cat's head was placed in a stereotactic frame. With microsurgical techniques, the left orbit was exenterated, and the optic foramen and optical fissure was enlarged with a dental drill to expose the dura mater overlying the MCA close to its origin. Under the oper ating microscope, the dura was incised and the MCA ex posed. The trunk of the MCA and all visible branches of the lenticulostriate arteries were coagulated with a bi polar diathermy and divided with microscissors.
MK-801 « + )-5-Methyl-l0, II-dihydro-5H-dibenzo (a,d) cyclohepten-5, 10-imine maleate, 5 mg/kg) dissolved in saline was administered as a slow (5 min) intravenous injection, 2 h after the occlusion of the MCA. Six hours after the occlusion of the middle cerebral artery, the cat was killed by transcardiac perfusion fixation with FAM, (40% formaldehyde, glacial acetic acid, and methanol in a ratio 1: 1:8) as described previously (Brown and Brierley, 1968) . Briefly, the cat was placed in a supine position and heparinised. A thoracotomy was performed, and a can nula was introduced into the ascending aorta via the left ventricle. Physiological saline was infused, at a pressure equivalent to mean arterial pressure, for 10 s. This was followed immediately by 1.5 I of FAM fixative at the same pressure. After perfusion, the cats were decapitated and the head was stored in fixative at 4°C for at least 12 h. The brain was then removed. After the left side of the forebrain was marked with India ink, the hindbrain was detached by a cut through the midbrain and the cerebral hemispheres were cut into five equally spaced coronal blocks. These blocks were embedded in paraffin wax, and sections 7 -8 fLm thick were cut at 200 fLm intervals throughout the specimens (�140 sections from each fore brain). The sections were stained by haematoxylin and eosin and by a method combining cresyl violet and Luxol fast blue. Those sections that corresponded most closely to 16 stereotactically predetermined coronal planes of cut brain from the atlas of Reinoso-Suarez (1961) were exam ined by conventional light microscopy by one of us (D.I.G.) without prior knowledge of the animal's history. Any abnormalities were charted on the diagrams and formed the basis of quantitative assessment of ischaemic brain damage as described in detail previously for the rat (Osborne et aI., 1987) .
The area of ischaemic damage in the cerebral hemi sphere, cerebral cortex, and caudate nucleus was deter mined from the diagrams, at each of the 16 coronal planes, by use of a computer-based image analysis system (Quantimet 970, Cambridge Instruments, Cam bridge, U.K.). The volumes of ischaemic damage were J Cereb Blood Flow Metab, Vol. 8, No.5, 1988 calculated from the areas of damage at the different co ronal planes and their anteroposterior coordinates.
Statistical analysis
Data are presented as mean ± SEM. Statistical com parison for the cardiovascular and respiratory variables between the two experimental groups was performed with the two-tailed Student's t test. The volumes of ischaemic damage in the drug-treated group were not dis tributed normally. Therefore, the significance of the re duction in the volumes of ischaemic damage was as sessed with a one-tailed Mann-Whitney U-test.
RESULTS
The cardiovascular and respiratory status of the control and MK-801-treated groups at MCA occlu sion and at the time of drug administration are shown in Ta ble 1. The levels of all physiological variables remained close to these levels throughout the experimental period. There were no significant differences between the two experimental groups in any of the measured physiological variables at any time point.
The administration of MK-801 elicited a small consistent increase (-20 mm Hg) in mean arterial blood pressure. The hypertension was relatively transient: within 10 min of drug administration, the levels of arterial pressure had returned to their pre drug levels. The administration of the vehicle (sa line) did not alter MABP.
Neuropathological examination
All brains were judged to be well perfusion-fixed, as evidenced by good neuronal morphology, the ab sence of intravascular blood, and the lack of cyto logical artifacts such as "dark cells" or "hydropic cells" (Brown and Brierley, 1968; Cammermeyer, 1961) . Coronal sectioning of the brains revealed the interior of the brains to be well fixed, except in the deeper portions of the left hemisphere, where zones of pink discolouration could be seen. Isch aemic damage was observed only within the terri tory of the occluded MCA, i.e., in the dorsolateral cortex and in the neostriatum. These areas showed the morphological characteristics of early infarc tion, with the neurones displaying the features of the ischaemic cell process (microvaculation, shrinkage, triangulation, and hyperchromasia of the cell body and nucleus) as described by Brown and Brierley (1968) .
Volumetric assessment of the ischaemic damage
The administration of MK-801 (5 mg/kg) 2 h after MCA occlusion reduced significantly the volume of ischaemic damage in the cerebral hemisphere and cortex that resulted from occlusion of the MCA (Fig. 1, Ta ble 2) . The volume of ischaemic damage Data are presented as mean ± SEM. Vehicle (n = 8); MK-80I (n = 7). There are no significant differences between the groups at either time point.
in the caudate nucleus was altered minimally by treatment with MK-801. No significant correlation could be demonstrated between the ischaemic volume and MAP at any time point during the post occlusion period. The magnitude of the MK-80l in duced hypertension did not correlate with the volume of ischaemic damage in individual animals.
There was considerable interanimal variability in the volumes of ischaemic tissue in the cerebral cortex. In the control group, two of the eight cats had ischaemic lesions <2% of the total cortical volume. In the MK-801-treated group, six of the seven cats had ischaemic lesions <2% of the total cortical volume. The remaining cat in the MK-801treated group had a very large volume of ischaemic tissue (47% of the ipsilateral cortex), a lesion size exceeded in only one animal in the control group. The ischaemic areas were reduced in every co ronal plane in the MK-801-treated animals (Fig. 2) , but this reflects simply the preponderance of small lesions in the group, rather than anterior-posterior differences in the susceptibility of ischaemic cortex to modification by the agent.
DISCUSSION
Cerebral ischaemia is associated with a marked elevation in the extracellular concentration of glu tamate (Benveniste et aI., 1984; Drejer et aI., 1985; Hagberg et aI., 1985 Hagberg et aI., , 1987 . High concentrations of glutamate and glutamate receptor agonists are known to be neurotoxic to neurones both in vitro and in vivo (Meldrum, 1985; Rothman and Olney, 1987 ). The precise mechanisms by which glutamate exerts its neurotoxic effects in vivo remain to be established, but there is growing evidence from in vitro investigations implicating calcium influx in the pathogenesis of brain damage initiated by glutamate (Rothman and Olney, 1987) . In neocortical cell cul tures exposed transiently to glutamate, there is an immediate cellular swelling, which is associated with chloride and sodium influx; the irreversible damage and neuronal disintegration that occurs over the subsequent 24 h is due principally to the transmembrane influx of calcium (Choi, 1987) . The NMDA receptor subtype appears to play the dominant role in mediating the glutamate-induced lethal influx of calcium in neurones in culture (Choi et aI., 1987) . Data such as these provide the ratio nale for the use of NMDA receptor antagonists in the treatment of cerebral ischaemia. It is worth em phasising that while glutamate and calcium may play a role in ischaemic damage to neurones, that role is likely to be only one factor in a complex se quence of neurochemical and ionic events that re sults ultimately in neuronal death.
Pretreatment with competitive and noncompeti tive antagonists of NMDA receptors ameliorates the effects of cerebral ischaemia in a number of an- imal models. Intrahippocampal injections of AP7 prior to the induction of ischaemia reduces the acute neuronal loss in the rat hippocampus pro duced by bilateral carotid artery occlusion and hy potension (Simon et aI., 1984) . Tr eatment with MK-801 or 3-(2-carboxypiperazin-4yl)propyl-l phosphonic acid (CPP) reduces the degeneration of hippocampal neurones in the gerbil 4 days after temporary bilateral carotid artery occlusion (Gill et aI., 1987; Boast et aI., 1988) . Pre-treatment with MK-801 reduces by 50% the volume of ischaemic damage in the cerebral hemisphere that is seen after permanent MCA occlusion in the cat (Ozyurt et aI., 1988) . The present report provides evidence from the same experimental model that the volume of ischaemic damage in the cerebral hemisphere and cortex can be reduced significantly with even when the treatment is initiated 2 h after the induction of cerebral ischaemia. This implies that the sequence of cellular events that involves gluta mate and that leads to cell death may be reversible for several hours after the primary insult. There is some evidence in favour of such a view. Intracere bral injections of NMDA induce neuronal degener-
ation, and this can be attenuated to a similar degree either by pretreatment with MK-801 or by treat ment with MK-801 initiated up to 5 h after adminis tration of the amino acid (Foster et aI., 1987a (Foster et aI., , 1987b . In nonhuman primates and cats, the ulti mate size of the ischaemic lesion is not finally es tablished until at least 3 h after MCA occlusion, and the amount of irreversible brain damage after MCA occlusion is a function of both the duration and the magnitude of the cerebral hypoperfusion (Jones et aI., 1981; Weinstein et al., 1986) . It remains to be established whether the protection MK-801 affords against early ischaemic damage is ultimately re flected in a markedly reduced volume of overt in farction or whether the development of the infarc tion is merely delayed. In neonatal animals, MK-801 treatment up to 75 min after a period of hypoxia can attenuate gross morphological changes in the cerebral hemisphere, assessed 5 days after the hypoxic episode (McDonald et aI., 1987) .
In the cat MCA occlusion models, the magnitude of the reduction in the volume of ischaemic tissue in the cerebral hemisphere is essentially similar (�50% of that in vehicle-treated controls) whether the NMDA antagonist MK-801 is administered prior to (Ozyurt et aI., 1988) or 2 h after the perma nent occlusion of the middle cerebral artery (this study). The statistical significance of the anti ischaemic effects of MK-801 was less with delayed treatment, but the statistical analysis is influenced greatly by the single drug-treated animal with a very large ischaemic lesion (see Fig. 1 ). In addition, the size of the ischaemic lesion in the vehicle treated controls in the present study was smaller than in the control group in our previous study with the same experimental design (Ozyurt et aI., 1988) . It is unclear whether the difference reflects subtle variations between the operative techniques and, especially, the point of occlusion of the MCA, as performed by two experienced neurosurgeons or whether it reflects differences in collateral blood flow to ischaemic cortex in different batches of an imals. However, it does emphasise the self-evident but often neglected importance of conducting con temporaneous, randomised control experiments, rather than using values from a historic series of control experiments. The transient increase in arterial pressure (�20 mm Hg) associated with the administration of MK-801 may contribute to the reduction in size of the ischaemic lesion that was observed in the present study. After MCA occlusion in the cat, cor tical blood flow via collateral vessels is extremely sensitive to changes in arterial pressure (Shima et aI., 1983) . The contribution of improved collateral blood flow, which results from the drug-induced hypertension, to the reduction in the lesion size with MK-801 is likely to be modest. The period of hypertension is short; within 10 min, arterial pres sure had returned to predrug levels. In our previous study in cats, MK-801 pretreatment improved his topathological outcome, although the period of hy pertension occurred 30 min before occlusion of the artery (Ozyurt et aI., 1988) . Moreover, in the halo thane-anaesthetised rat, MK-801 reduces the volume of ischaemic damage after MCA occlusion, despite inducing sustained hypotension (C. K. Park et aI., 1988) . While perfusion pressure is a critical variable in cerebral ischaemia, the beneficial effects of MK-801 cannot be attributed to its effects upon perfusion pressure.
In conclusion, the present report indicates that the amount of ischaemic brain damage can be re duced by MK-801 in the cat model of focal cerebral ischaemia, even when this NMDA antagonist is ad ministered 2 h after the induction of the ischaemia. If a similar time window for therapeutic interven tion exists in humans, it would greatly extend the potential of such agents in the treatment of focal cerebral ischaemia.
